INDV: Indivior PLC Stock

by  •  • Comments Off on INDV: Indivior PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,050.07
Enterprise Value ($M) 1,064.07
Book Value ($M) -205.00
Book Value / Share -1.65
Price / Book -5.12
NCAV ($M) -842.00
NCAV / Share -6.78
Price / NCAV -1.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.02
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.69
Current Ratio 0.88

Balance Sheet (mrq) ($M)
Current Assets 829.00
Assets 1,466.00
Liabilities 1,671.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,188.00
Operating Income 256.00
Net Income -48.00

Cash Flow Statement (mra) ($M)
Cash From Operations 21.00
Cash from Investing 69.00
Cash from Financing -87.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Flynn James E
01-17 13D/A Two Seas Capital LP
12-18 13D/A Oaktree Capital Holdings, LLC
11-14 13G/A Scopia Capital Management Lp 4.30 -51.80
04-09 13G SG Americas Securities, LLC 5.17
2024-02-08 13G Morgan Stanley 7.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-24 131,518 1,019,404 12.90
2025-02-21 327,815 1,668,719 19.64
2025-02-20 502,632 2,660,721 18.89
2025-02-19 155,730 846,099 18.41

(click for more detail)

Similar Companies
IMUX – Immunic, Inc. IMVT – Immunovant, Inc.
INBX – Inhibrx Biosciences, Inc. INNV – InnovAge Holding Corp.
INSM – Insmed Incorporated


Financial data and stock pages provided by
Fintel.io